Free Trial

Centric Wealth Management Has $1.97 Million Holdings in Molina Healthcare, Inc. (NYSE:MOH)

Molina Healthcare logo with Medical background
Remove Ads

Centric Wealth Management lowered its holdings in Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 44.1% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 6,752 shares of the company's stock after selling 5,332 shares during the quarter. Centric Wealth Management's holdings in Molina Healthcare were worth $1,965,000 at the end of the most recent reporting period.

Several other hedge funds have also recently modified their holdings of MOH. True Wealth Design LLC lifted its position in Molina Healthcare by 2,500.0% during the third quarter. True Wealth Design LLC now owns 104 shares of the company's stock valued at $36,000 after purchasing an additional 100 shares during the period. Versant Capital Management Inc lifted its holdings in shares of Molina Healthcare by 83.1% in the 4th quarter. Versant Capital Management Inc now owns 163 shares of the company's stock valued at $47,000 after buying an additional 74 shares during the period. Wingate Wealth Advisors Inc. purchased a new position in Molina Healthcare during the fourth quarter valued at approximately $52,000. EverSource Wealth Advisors LLC lifted its holdings in Molina Healthcare by 81.5% in the fourth quarter. EverSource Wealth Advisors LLC now owns 196 shares of the company's stock valued at $57,000 after acquiring an additional 88 shares during the period. Finally, Whittier Trust Co. of Nevada Inc. boosted its position in Molina Healthcare by 337.0% in the 4th quarter. Whittier Trust Co. of Nevada Inc. now owns 201 shares of the company's stock worth $58,000 after purchasing an additional 155 shares in the last quarter. Hedge funds and other institutional investors own 98.50% of the company's stock.

Remove Ads

Molina Healthcare Stock Up 0.2 %

MOH stock traded up $0.56 during midday trading on Wednesday, reaching $328.27. The company had a trading volume of 384,080 shares, compared to its average volume of 634,557. The company has a current ratio of 1.62, a quick ratio of 1.62 and a debt-to-equity ratio of 0.69. Molina Healthcare, Inc. has a 1 year low of $262.32 and a 1 year high of $384.35. The company has a 50 day moving average of $304.95 and a two-hundred day moving average of $308.51. The company has a market capitalization of $17.96 billion, a P/E ratio of 16.07, a PEG ratio of 1.06 and a beta of 0.56.

Molina Healthcare (NYSE:MOH - Get Free Report) last announced its earnings results on Wednesday, February 5th. The company reported $5.05 earnings per share for the quarter, missing the consensus estimate of $5.74 by ($0.69). Molina Healthcare had a net margin of 2.90% and a return on equity of 28.13%. On average, equities research analysts expect that Molina Healthcare, Inc. will post 24.4 earnings per share for the current fiscal year.

Insider Activity

In other Molina Healthcare news, Director Steven J. Orlando sold 1,000 shares of the business's stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $301.33, for a total value of $301,330.00. Following the sale, the director now owns 17,375 shares in the company, valued at approximately $5,235,608.75. The trade was a 5.44 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. 1.10% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

MOH has been the subject of several recent analyst reports. Barclays cut their price target on Molina Healthcare from $372.00 to $339.00 and set an "equal weight" rating for the company in a research note on Friday, February 7th. Wells Fargo & Company raised Molina Healthcare from an "equal weight" rating to an "overweight" rating and upped their target price for the stock from $295.00 to $372.00 in a research note on Wednesday, March 5th. StockNews.com raised shares of Molina Healthcare from a "hold" rating to a "buy" rating in a report on Wednesday, March 26th. Stephens reiterated an "equal weight" rating and issued a $345.00 target price on shares of Molina Healthcare in a research report on Thursday, February 6th. Finally, UBS Group reduced their price target on shares of Molina Healthcare from $374.00 to $325.00 and set a "neutral" rating for the company in a research report on Friday, February 7th. Six research analysts have rated the stock with a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $348.75.

Get Our Latest Analysis on Molina Healthcare

About Molina Healthcare

(Free Report)

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.

Featured Articles

Institutional Ownership by Quarter for Molina Healthcare (NYSE:MOH)

Should You Invest $1,000 in Molina Healthcare Right Now?

Before you consider Molina Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.

While Molina Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Is Micron on Par with AMD? BUY Now or DEAD Money?

Is Micron on Par with AMD? BUY Now or DEAD Money?

Is the dip in Micron's stock price a golden buying opportunity or another case of dead money? MarketBeat's Thomas Hughes weighs in, comparing Micron to AMD.

Recent Videos

Donald Trump Owns These 7 Stocks, Should You?
 5 Stocks to BUY NOW in April 2025
3 Bank Stocks Defying Market Turmoil—Cheap Options Trades!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads